McKesson Acquires Cancer-Care Company, Oncology Pharmacy-Services Firm
The San Francisco company's CEO said the move will allow the company to offer more services to its manufacturer partners, expand its drug distribution and provide care management for payers.
The Wall Street Journal:
McKesson To Buy Two Cancer-Focused Firms For $1.2 Billion
McKesson Corp. agreed to acquire cancer-care company Vantage Oncology LLC and oncology pharmacy-services firm Biologics Inc. in separate deals with a combined value of roughly $1.2 billion. McKesson’s shares rose 3.5% to $160.08 in recent premarket trading. The San Francisco company said the acquisitions will expand the scale of its specialty-drug distribution operations and increase its other capabilities, including its cancer-focused pharmacy offerings. (Stynes, 2/25)